Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4606 AL 4620

Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?

MohanaSundaram A, Thukani Sathanantham S, Sveikata L, Lalla RS, Sveikatienė R, Kaushik A, Velayutham R.

Expert Rev Neurother. 2022 Apr;22(4):283-286. doi: 10.1080/14737175.2022.2053112. Epub 2022 Mar 28.

Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies

Protto V, Marcocci ME, Miteva MT, Piacentini R, Li Puma DD, Grassi C, Palamara AT, De Chiara G.

Curr Opin Pharmacol. 2022 Apr;63:102200. doi: 10.1016/j.coph.2022.102200. Epub 2022 Mar 8.

The Implication of Physiological Ketosis on The Cognitive Brain: A Narrative Review

Altayyar M, Nasser JA, Thomopoulos D, Bruneau M Jr.

Nutrients. 2022 Jan 25;14(3):513. doi: 10.3390/nu14030513.

Cerebral microinfarct is emergency consequence of Alzheimer's disease: a new insight into development of neurodegenerative diseases

Lin X, Fan Y, Zhang F, Lin Y.

Int J Biol Sci. 2022 Jan 24;18(4):1569-1579. doi: 10.7150/ijbs.55419. eCollection 2022.

A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer's disease

Phuna ZX, Madhavan P.

Int J Neurosci. 2023 Dec;133(10):1071-1089. doi: 10.1080/00207454.2022.2045290. Epub 2022 Mar 14.

Fatty acids as biomodulators of Piezo1 mediated glial mechanosensitivity in Alzheimer's disease

Ivkovic S, Major T, Mitic M, Loncarevic-Vasiljkovic N, Jovic M, Adzic M.

Life Sci. 2022 May 15;297:120470. doi: 10.1016/j.lfs.2022.120470. Epub 2022 Mar 10.

Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis

McFarland KN, Chakrabarty P.

Neurotherapeutics. 2022 Jan;19(1):186-208. doi: 10.1007/s13311-021-01179-3. Epub 2022 Mar 14.

Association of 1-year change in neuroticism and 3-year change in cognitive performance among older depressed adults

Steffens DC, Manning KJ, Wu R, Grady JJ.

Int Psychogeriatr. 2022 Jul;34(7):645-650. doi: 10.1017/S1041610222000084. Epub 2022 Mar 15.

Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives

Fisher RA, Miners JS, Love S.

Brain Pathol. 2022 Nov;32(6):e13061. doi: 10.1111/bpa.13061. Epub 2022 Mar 14.

Reimagining cholinergic therapy for Alzheimer's disease

Giacobini E, Cuello AC, Fisher A.

Brain. 2022 Jul 29;145(7):2250-2275. doi: 10.1093/brain/awac096.

[Causal treatment of Alzheimer's disease: amyloid antibodies]

Pawlowski M, Warnecke T.

Inn Med (Heidelb). 2022 Sep;63(9):1000-1008. doi: 10.1007/s00108-022-01291-2. Epub 2022 Mar 15.

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Byun J, Lee DY, Jeong CW, Kim Y, Rhee HY, Moon KW, Heo J, Hong Y, Kim WJ, Nam SJ, Choi HS, Park JI, Chun IK, Bak SH, Lee K, Byeon GH, Kim KL, Kim JA, Park YJ, Kim JH, Lee EJ, Lee SA, Kwon SO, Park SW, Kasani PH, Kim JK, Kim Y, Kim S, Jang JW.

Sci Rep. 2022 Mar 15;12(1):4451. doi: 10.1038/s41598-022-08595-1.

The key roles of organelles and ferroptosis in Alzheimer's disease

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC.

J Neurosci Res. 2022 Jun;100(6):1257-1280. doi: 10.1002/jnr.25033. Epub 2022 Mar 16.

Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs

Medrano-Jiménez E, Meza-Sosa KF, Urbán-Aragón JA, Secundino I, Pedraza-Alva G, Pérez-Martínez L.

J Leukoc Biol. 2022 Jul;112(1):47-77. doi: 10.1002/JLB.3MR1021-531R. Epub 2022 Mar 16.

Tau Pathology, Metal Dyshomeostasis and Repetitive Mild Traumatic Brain Injury: An Unexplored Link Paving the Way for Neurodegeneration

Juan SMA, Daglas M, Adlard PA.

J Neurotrauma. 2022 Jul;39(13-14):902-922. doi: 10.1089/neu.2021.0241.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias